BASF

***Live: Tuesday, December 1, 2020 at 10am EST| 9am CST| 3pm GMT| 4pm CET***Formulators face special challenges with developing parenteral drugs to achieve the needed stability, efficacy and sterility. Learn how high purity excipients can be used to address formulation issues, while complying with regulatory requirements.*** On demand available after final airing until Dec. 1, 2021.***

*** Live: Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT *** 2020 Bio/Pharma Virtual Congress: Join Pharmaceutical Technology® and BioPharm International® for this online event that will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. ***On demand available after final airing until 11/11/2021

Online tool predicts the optimal formulation of drugs New way to predict compressibility and compactibility

Self-emulsifying drug delivery systems, or SEDDS, are arguably the most successful technology in the market today for taking poorly water-soluble APIs and turning them into bioavailable formulations. But where do you start? Learn about the physical chemistry of these systems, discuss testing options, and uncover 10 ready-to-use formulations to be used for your next project. Live: Thursday June 4, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST On Demand: available after airing until June 4, 2021 Register free

Drug developers are increasingly using topical dosage forms for numerous reasons, but several factors must be considered to optimize the API's functionality including excipient selection. Trends and Formulation Strategies for Topical Drugs explores this topic and other areas of interest to developers.

Looking to eliminate trial and error in the early stages of formulation development? Learn how the ZoomLab™ Virtual Formulation Assistant, can predict and optimize an oral solid dosage drug formulation more efficiently than with traditional approaches. Live: Tuesday, Apr. 21, 2020 at 9am EDT | 2pm BST | 3pm CEST On Demand: available after airing until Apr. 21, 2021 Register free

A core challenge among drug developers is working with challenging APIs, which are increasingly becoming more hydrophobic and/or with stronger crystal lattice structures, each ultimately poorly water soluble. This ebook covers a variety of important tools for formulators.

Perhaps it’s time for pharma to think about sustainable sourcing. Learn how the sourcing of pharma ingredients can contribute to the sustainability goals of pharmaceutical companies. Frank Romanski, Head of Global Marketing at BASF Pharma Solutions, and Sebastian Form, Director of Applied Sustainability at BASF Nutrition & Health, will talk about sourcing initiatives BASF has undertaken that can help advance customer sustainability goals. On demand available after airing until Nov. 7, 2020 Register free

Poorly-soluble APIs present formulation and development challenges. Excipient selection and manufacturing process development are crucial. Continuous twin-screw granulation is gaining acceptance as a manufacturing technology to address issues presented by these APIs and is offering high production capacity in a small footprint. In this dedicated dialogue, solubility enhancement expert Andreas Gryczke from BASF will answer additional questions that have been posed in our recent webinar on Twin Screw Wet Granulation for Solubility Enhancement of Poorly Water-Soluble Drugs.

Excipients are crucial for effective drug formulation, and excipient manufacturers continue to make advances in technology designed to address the formulation challenges presented by new drug substances. Pharmaceutical Technology magazine talked with Dr. Bernhard Fussnegger, Global Development and Technical Marketing at BASF, about the excipient developer’s family of peroxide-free excipients that are recommended for APIs sensitive to oxidation.

Best Practices for Overcoming Softgel Coating Challenges